Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
23.69
+0.55 (2.38%)
Mar 9, 2026, 4:00 PM EDT - Market closed
AAPG Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,052 | 1,812 | 995 | 851 | 932 | 1,096 | |
| Market Cap Growth | 31.69% | 82.10% | 16.89% | -8.64% | -15.02% | 39.78% | |
| Enterprise Value | 2,061 | 1,896 | 1,009 | 830 | 798 | 1,045 | |
| PS Ratio | 37.64 | 13.48 | 31.78 | 27.99 | 212.05 | 574.86 | |
| PB Ratio | 21.75 | 48.23 | 99.87 | 14.36 | 4.79 | 8.45 | |
| P/TBV Ratio | 25.78 | 80.87 | - | 19.59 | 5.15 | 9.47 | |
| EV/Sales Ratio | 37.80 | 14.11 | 32.24 | 27.31 | 181.70 | 548.17 | |
| Debt / Equity Ratio | 2.54 | 6.09 | 25.42 | 4.39 | 0.88 | 0.63 | |
| Net Debt / Equity Ratio | 0.08 | 1.47 | 9.84 | 0.71 | -0.54 | -0.59 | |
| Net Debt / EBITDA Ratio | -0.05 | -1.34 | -0.85 | -0.34 | 0.73 | 0.75 | |
| Net Debt / FCF Ratio | -0.25 | -2.96 | -0.90 | -0.34 | 0.64 | 0.58 | |
| Asset Turnover | 0.13 | 0.38 | 0.08 | 0.07 | 0.01 | 0.01 | |
| Inventory Turnover | 3.70 | 2.56 | 2.38 | 3.29 | - | - | |
| Quick Ratio | 1.40 | 1.17 | 1.35 | 1.78 | 5.05 | 3.77 | |
| Current Ratio | 1.54 | 1.26 | 1.44 | 1.86 | 5.22 | 3.91 | |
| Return on Equity (ROE) | -159.65% | -235.32% | -386.28% | -107.45% | -75.18% | -78.02% | |
| Return on Assets (ROA) | -22.77% | -9.25% | -20.92% | -19.14% | -24.97% | -29.14% | |
| Return on Capital Employed (ROCE) | -62.00% | -26.10% | -57.00% | -45.30% | -36.20% | -47.00% | |
| Earnings Yield | -7.89% | -3.07% | -13.12% | -15.04% | -13.22% | -9.47% | |
| FCF Yield | -1.53% | -1.03% | -10.95% | -14.60% | -17.57% | -12.02% | |
| Buyback Yield / Dilution | -12.40% | -7.00% | -7.07% | -3.56% | -17.93% | -84.97% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.